Array BioPharma To Present At The LEERINK Partners 7th Annual Global Healthcare Conference

BOULDER, Colo., Feb. 7, 2018 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the LEERINK Partners 7^th Annual Global Healthcare Conference in New York.  The public is welcome to participate in the conference through a webcast on the Array BioPharma website.   

About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.  Nine registration studies are currently advancing related to seven Array-owned or partnered drugs: binimetinib (MEK162), encorafenib (LGX818), selumetinib (partnered with AstraZeneca), danoprevir (partnered with Roche), ipatasertib (partnered with Genentech), larotrectinib (partnered with Loxo Oncology) and tucatinib (partnered with Cascadian Therapeutics).  For more information on Array, please go to www.arraybiopharma.com.

CONTACT: 
Andrea N. Flynn, Ph.D.
Senior Director, Investor Relations & Corporate Communications
(303) 381-6600
ir@arraybiopharma.com

View original content with multimedia:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-leerink-partners-7th-annual-global-healthcare-conference-300595364.html

SOURCE Array BioPharma Inc.